Completed NA INTERVENTIONAL 1-arm NCT00530712

Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis (DURABILITY II)

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II

Sponsor: Medtronic Endovascular

Conditions Claudication Peripheral Vascular Diseases

Interventions PROTÉGÉ® EverFlex™ Self-Expanding Stent System

Updated 7 times since 2017 Last updated: Feb 14, 2019 Started: Aug 31, 2007 Primary completion: Mar 31, 2012 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Claudication and Peripheral Vascular Diseases and is currently completed. Medtronic Endovascular leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA

Phase: PHASE2_PHASE3 → NA
Jun 2018 — Mar 2019 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Endovascular

Data source: Medtronic Endovascular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.